Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Blood
Published October 5, 2026
Diagnosis and Management of Chronic Lymphocytic Leukemia with TP53 Loss of Function in the Novel ...
October 6, 2026
Medspoke
Medspoke
Blood
Published October 5, 2026
00:00
--:--
STAG2 mutations fine-tune the ALK-driven oncogenic program in ALK-positive anaplastic large cell ...
October 6, 2026
Share
STAG2 mutations fine-tune the ALK-driven oncogenic program in ALK-positive anaplastic large cell lymphoma.
https://www.medspoke.co/channel_journal?id=683&tap_id=15131
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Blood
Published October 5, 2026
Mosunetuzumab and Polatuzumab Vedotin as First-line Treatment for Large B Cell Lymphoma in Older ...
October 6, 2026
Why are you reporting this TALK?